EMMAEmmaus Life Sciences, Inc.vs its industry peers
A metric-by-metric comparison of Emmaus Life Sciences, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMMAThis | $84M#3 | — | — | 6.8x#3 | -25.2%#4 | -16.1%#3 | 1.9%#1 | — | — | 4#1 | — | — |
| TNXP | $88M#1 | — | 0.4x#1 | 6.7x#2 | 29.8%#2 | 4.6%#2 | -959.1%#3 | -55.8%#2 | -234.8%#1 | — | -71.7%#1 | — |
| LEXX | $87M#2 | — | 18.3x#3 | 122.9x#4 | 52.0%#1 | -105.4%#4 | -1683.0%#4 | -251.2%#3 | — | — | -76.4%#2 | — |
| CPIX | $71M#4 | — | 4.1x#2 | 1.6x#1 | 17.6%#3 | 56.2%#1 | -6.3%#2 | -16.3%#1 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice